e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Can/Fite
Recent news which mentions Can/Fite
Industry Analysts Seemingly Sing Praises For This Stock After Phase III Trial Results
July 14, 2022
Tickers
CANF
JNJ
MRK
PFE
Tags
Penny Stocks
Biotech
Can/Fite
From
Benzinga
CANF: Beginning to Flex Its Muscles; Initiating With OUTPERFORM Rating, $6.00 Price Target
February 23, 2022
Tickers
CANF
Tags
Press Releases
Benzinga
General
From
Benzinga
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
Tickers
AMGN
CANF
CELG
PFE
Tags
CELG
Partner Content
Market News
From
Benzinga
Race to Effective Psoriasis Treatment: Can-Fite's Piclidenoson May Edge Over High-Flying Amgen's Otezla. Here's Why
October 20, 2021
Tags
Benzinga
General
Partner Content
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.